Fight the Fakes Infographic – Same Packaging, Same Shape and Same Color… But Fakes! (Spanish Version)
About IFPMA
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations around the world. Our industry’s almost three million employees discover, develop, and deliver medicines and vaccines that advance global health. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. For more information, visit ifpma.org.
Learn more
Related news and resources
Global regulators and biopharmaceutical and vaccine industry to share experiences with managing pharmaceutical quality systems
On 20 July 2023, the International Coalition of Medicines Regulatory Authorities (ICMRA) is hosting a virtual workshop on the development of a global Pharmaceutical Quality Knowledge Management System (PQ KMS), which aims to facilitate the exchange of knowledge related to pharmaceutical quality amongst national regulatory authorities worldwide.
Read moreG20 side event on “Envisaging a Global R&D Network for Research in Vaccines, Therapeutics, and Diagnostics (VTDs) to enhance Prevention, Preparedness, and Response (PPR)”
On 6 June, IFPMA delivered a statement at the G20 “Strengthening Global Collaboration on Research and Development in MCMs (Diagnostics, Vaccines, and Therapeutics” side event on “Envisaging a Global R&D Network for Research in VTDs to enhance PPR” at the G20 3rd Health Working Group Meeting in Hyderabad.
Read moreNavigating the ECOWAS Joint Assessment Procedure
The ECOWAS Joint Assessment Procedure is a collaborative initiative among 15 National Regulatory Agencies in West Africa that ensures harmonized and streamlined market authorization of medical products across the region. This infographic provides an overview of key steps and timelines applicants need to bear in mind during the Joint Assessment Procedure.
Read more